Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Degradation trumps mutations in cancer.

Science (New York, N.Y.) - 2 Feb 2024

Davis R Eric, Westin Jason R

Abstract excerpt

Redirecting targeted proteins for degradation can overcome acquired drug resistance.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Line, Tumor
Share to Drug Resistance, Neoplasm
Share to Leukemia, Lymphocytic, Chronic, B-Cell
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Protein Kinase Inhibitors

Share to Proteolysis

Source

Identifiers

PMID: 38301021
DOI: 10.1126/science.adn4945

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Degradation trumps mutations in cancer.PMID 38301021Read ↗

Targeted protein degradation in oncology: novel therapeutic opportunity for solid tumours?Semantic proximity Read ↗

PROTAC’ing oncoproteins: targeted protein degradation for cancer therapySemantic proximity Read ↗

Targeting the Interplay of Proteins through PROTACs for the Management of Cancer and Associated DisordersSemantic proximity Read ↗

Protein degradation: expanding the toolbox to restrain cancer drug resistanceSemantic proximity Read ↗

Cracking the EGFR code: Cancer biology, resistance mechanisms, and future therapeutic frontiers.Semantic proximity Read ↗

Overcoming Cancer Drug Resistance Utilizing PROTAC TechnologySemantic proximity Read ↗

Clinical Translation of Targeted Protein DegradersSemantic proximity Read ↗

Proteasome dysregulation in human cancer: implications for clinical therapiesSemantic proximity Read ↗

PROTACs: Current and Future Potential as a Precision Medicine Strategy to Combat CancerSemantic proximity Read ↗

New-generation advanced PROTACs as potential therapeutic agents in cancer therapySemantic proximity Read ↗

Progress of small molecules for targeted protein degradation: PROTACs and other technologiesSemantic proximity Read ↗

mRNA splicing variants: exploiting modularity to outwit cancer therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.